Citation: Mp. Barnes et al., Task force on minimum standards for health care of people with multiple sclerosis: June 1999, EUR J NEUR, 8(3), 2001, pp. 215-220
Authors:
Willison, HJ
Ang, W
Gilhus, NE
Graus, F
Liblau, R
Vedeler, C
Vincent, A
Citation: Hj. Willison et al., EFNS Task Force Report: a questionnaire-based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres, EUR J NEUR, 7(6), 2000, pp. 625-628
Authors:
Romi, F
Skeie, GO
Vedeler, C
Aarli, JA
Zorzato, F
Gilhus, NE
Citation: F. Romi et al., Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis - A study of IgG subclasses and clinical correlations, J NEUROIMM, 111(1-2), 2000, pp. 169-176
Authors:
Mygland, A
Vincent, A
Newsom-Davis, J
Kaminski, H
Zorzato, F
Agius, M
Gilhus, NE
Aarli, JA
Citation: A. Mygland et al., Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia, ARCH NEUROL, 57(4), 2000, pp. 527-531
Citation: F. Romi et al., The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies, ARCH NEUROL, 57(11), 2000, pp. 1596-1600